Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Military Personnel | 14 | 2024 | 92 | 6.290 |
Why?
|
| Petroleum Pollution | 7 | 2021 | 11 | 3.710 |
Why?
|
| Environmental Pollutants | 6 | 2024 | 52 | 3.090 |
Why?
|
| Occupational Exposure | 17 | 2017 | 87 | 3.050 |
Why?
|
| Thyroid Neoplasms | 5 | 2024 | 425 | 2.000 |
Why?
|
| Polychlorinated Biphenyls | 4 | 2024 | 7 | 1.900 |
Why?
|
| Petroleum | 5 | 2021 | 13 | 1.900 |
Why?
|
| Emergency Responders | 3 | 2018 | 7 | 1.690 |
Why?
|
| Water Pollutants, Chemical | 4 | 2021 | 134 | 1.480 |
Why?
|
| DNA Methylation | 5 | 2016 | 666 | 1.410 |
Why?
|
| Internship and Residency | 4 | 2024 | 1062 | 1.220 |
Why?
|
| Early Detection of Cancer | 3 | 2023 | 422 | 1.180 |
Why?
|
| Internal Medicine | 4 | 2024 | 362 | 1.160 |
Why?
|
| Occupational Diseases | 4 | 2017 | 55 | 1.130 |
Why?
|
| Carcinoma, Papillary | 2 | 2018 | 156 | 1.050 |
Why?
|
| Ships | 3 | 2017 | 5 | 0.980 |
Why?
|
| Curriculum | 6 | 2024 | 572 | 0.950 |
Why?
|
| Hydrocarbons, Chlorinated | 2 | 2019 | 4 | 0.940 |
Why?
|
| Pesticides | 7 | 2016 | 29 | 0.920 |
Why?
|
| Health Equity | 2 | 2023 | 96 | 0.900 |
Why?
|
| Case-Control Studies | 13 | 2024 | 1864 | 0.900 |
Why?
|
| Endocrine Disruptors | 1 | 2024 | 27 | 0.890 |
Why?
|
| Agricultural Workers' Diseases | 9 | 2015 | 18 | 0.880 |
Why?
|
| Students, Health Occupations | 1 | 2023 | 5 | 0.870 |
Why?
|
| Sexual Health | 1 | 2022 | 17 | 0.820 |
Why?
|
| Humans | 66 | 2024 | 89924 | 0.790 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2012 | 14 | 0.780 |
Why?
|
| Vaginal Smears | 1 | 2021 | 71 | 0.770 |
Why?
|
| Respiratory Tract Diseases | 3 | 2018 | 45 | 0.750 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 98 | 0.740 |
Why?
|
| Students, Medical | 2 | 2023 | 425 | 0.730 |
Why?
|
| Adult | 35 | 2024 | 26810 | 0.730 |
Why?
|
| Insecticides | 5 | 2010 | 27 | 0.720 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2020 | 3 | 0.700 |
Why?
|
| Female | 42 | 2024 | 46571 | 0.700 |
Why?
|
| Polybrominated Biphenyls | 1 | 2020 | 5 | 0.700 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2019 | 6 | 0.690 |
Why?
|
| Herbicides | 7 | 2015 | 36 | 0.690 |
Why?
|
| Education, Medical | 1 | 2023 | 243 | 0.690 |
Why?
|
| Breast Density | 1 | 2019 | 36 | 0.670 |
Why?
|
| Education, Medical, Graduate | 3 | 2024 | 401 | 0.670 |
Why?
|
| Middle Aged | 36 | 2024 | 26132 | 0.670 |
Why?
|
| Stomach Neoplasms | 3 | 2011 | 288 | 0.660 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 3021 | 0.640 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 1729 | 0.640 |
Why?
|
| Interleukin-16 | 1 | 2018 | 7 | 0.640 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 296 | 0.620 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 264 | 0.620 |
Why?
|
| DNA | 4 | 2016 | 1311 | 0.610 |
Why?
|
| Mortality | 3 | 2009 | 149 | 0.610 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 1185 | 0.610 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 163 | 0.610 |
Why?
|
| Women's Health | 3 | 2024 | 103 | 0.610 |
Why?
|
| Interleukin-15 | 1 | 2018 | 73 | 0.600 |
Why?
|
| Hot Temperature | 1 | 2018 | 207 | 0.600 |
Why?
|
| Prospective Studies | 18 | 2021 | 4325 | 0.570 |
Why?
|
| Construction Industry | 1 | 2017 | 1 | 0.570 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2017 | 2 | 0.570 |
Why?
|
| Environmental Exposure | 5 | 2021 | 334 | 0.570 |
Why?
|
| Male | 37 | 2024 | 42657 | 0.570 |
Why?
|
| Farmers | 1 | 2016 | 5 | 0.560 |
Why?
|
| Air Pollutants, Occupational | 1 | 2016 | 6 | 0.560 |
Why?
|
| Brain Neoplasms | 2 | 2024 | 783 | 0.560 |
Why?
|
| Ostomy | 1 | 2017 | 15 | 0.560 |
Why?
|
| North Carolina | 15 | 2016 | 51 | 0.560 |
Why?
|
| Huntington Disease | 1 | 2017 | 39 | 0.560 |
Why?
|
| Carcinogens | 5 | 2015 | 111 | 0.550 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 158 | 0.540 |
Why?
|
| Neoplasms | 14 | 2015 | 3065 | 0.540 |
Why?
|
| Iowa | 14 | 2016 | 35 | 0.540 |
Why?
|
| Occupational Health | 1 | 2016 | 36 | 0.540 |
Why?
|
| Glioma | 1 | 2018 | 294 | 0.520 |
Why?
|
| Patient Participation | 1 | 2018 | 226 | 0.520 |
Why?
|
| Thyrotropin | 1 | 2017 | 289 | 0.520 |
Why?
|
| Colonoscopy | 1 | 2017 | 281 | 0.510 |
Why?
|
| Gulf of Mexico | 3 | 2021 | 5 | 0.510 |
Why?
|
| Health Behavior | 1 | 2017 | 185 | 0.500 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 961 | 0.480 |
Why?
|
| Cyclonic Storms | 1 | 2014 | 4 | 0.470 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1054 | 0.470 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 155 | 0.460 |
Why?
|
| Cohort Studies | 13 | 2023 | 2887 | 0.450 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 1738 | 0.450 |
Why?
|
| Receptors, Progesterone | 2 | 2005 | 175 | 0.450 |
Why?
|
| Mesothelioma | 1 | 2017 | 320 | 0.440 |
Why?
|
| Receptors, Estrogen | 2 | 2005 | 394 | 0.420 |
Why?
|
| Acetamides | 2 | 2015 | 26 | 0.400 |
Why?
|
| Alu Elements | 1 | 2012 | 16 | 0.400 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 153 | 0.360 |
Why?
|
| Poisson Distribution | 7 | 2018 | 50 | 0.360 |
Why?
|
| Incidence | 10 | 2021 | 1601 | 0.350 |
Why?
|
| Young Adult | 7 | 2024 | 6408 | 0.340 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 115 | 0.340 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 980 | 0.340 |
Why?
|
| Atrazine | 2 | 2011 | 2 | 0.340 |
Why?
|
| Surveys and Questionnaires | 10 | 2022 | 2653 | 0.330 |
Why?
|
| Risk Assessment | 8 | 2023 | 2327 | 0.330 |
Why?
|
| Military Medicine | 1 | 2009 | 21 | 0.330 |
Why?
|
| Longevity | 1 | 2009 | 58 | 0.320 |
Why?
|
| Odds Ratio | 7 | 2012 | 682 | 0.320 |
Why?
|
| Permethrin | 1 | 2008 | 9 | 0.320 |
Why?
|
| United States | 9 | 2024 | 7102 | 0.310 |
Why?
|
| Organic Chemicals | 1 | 2008 | 34 | 0.310 |
Why?
|
| Logistic Models | 4 | 2020 | 1214 | 0.290 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 2369 | 0.290 |
Why?
|
| Topography, Medical | 1 | 2006 | 4 | 0.270 |
Why?
|
| Agriculture | 5 | 2010 | 39 | 0.260 |
Why?
|
| Age Factors | 5 | 2021 | 1880 | 0.250 |
Why?
|
| Aged | 17 | 2019 | 19240 | 0.250 |
Why?
|
| Adipose Tissue | 2 | 2005 | 262 | 0.250 |
Why?
|
| Pesticide Residues | 1 | 2005 | 2 | 0.250 |
Why?
|
| Risk | 2 | 2021 | 657 | 0.250 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 869 | 0.220 |
Why?
|
| Meningioma | 1 | 2024 | 62 | 0.220 |
Why?
|
| Meningeal Neoplasms | 1 | 2024 | 66 | 0.220 |
Why?
|
| Cadherins | 2 | 2016 | 163 | 0.220 |
Why?
|
| General Practitioners | 1 | 2023 | 11 | 0.220 |
Why?
|
| Veterans | 1 | 2024 | 85 | 0.210 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 3680 | 0.210 |
Why?
|
| Anxiety Disorders | 1 | 2024 | 152 | 0.210 |
Why?
|
| Drama | 1 | 2022 | 9 | 0.210 |
Why?
|
| Registries | 5 | 2019 | 808 | 0.210 |
Why?
|
| Antigens, CD | 2 | 2016 | 466 | 0.200 |
Why?
|
| Primary Prevention | 1 | 2023 | 82 | 0.200 |
Why?
|
| Risk Factors | 8 | 2023 | 5554 | 0.200 |
Why?
|
| Self Report | 2 | 2024 | 297 | 0.200 |
Why?
|
| American Cancer Society | 1 | 2021 | 13 | 0.200 |
Why?
|
| Confidence Intervals | 5 | 2011 | 221 | 0.190 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2021 | 33 | 0.190 |
Why?
|
| Intimate Partner Violence | 1 | 2021 | 28 | 0.190 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 2 | 2011 | 4 | 0.190 |
Why?
|
| Glioblastoma | 1 | 2024 | 267 | 0.190 |
Why?
|
| Patient Care | 1 | 2022 | 102 | 0.190 |
Why?
|
| Papillomavirus Vaccines | 1 | 2021 | 58 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2011 | 105 | 0.180 |
Why?
|
| Alabama | 1 | 2019 | 11 | 0.170 |
Why?
|
| Age Distribution | 2 | 2018 | 199 | 0.170 |
Why?
|
| Blast Injuries | 1 | 2020 | 12 | 0.170 |
Why?
|
| Guideline Adherence | 1 | 2021 | 234 | 0.170 |
Why?
|
| Sexual Behavior | 1 | 2022 | 312 | 0.170 |
Why?
|
| Contraception | 1 | 2020 | 93 | 0.170 |
Why?
|
| Communication | 1 | 2023 | 461 | 0.170 |
Why?
|
| Personal Protective Equipment | 1 | 2019 | 35 | 0.160 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 31 | 0.160 |
Why?
|
| Headache | 1 | 2019 | 73 | 0.160 |
Why?
|
| Counseling | 1 | 2020 | 166 | 0.160 |
Why?
|
| Baltimore | 2 | 2017 | 40 | 0.160 |
Why?
|
| Fungicides, Industrial | 2 | 2008 | 2 | 0.160 |
Why?
|
| Primary Health Care | 1 | 2022 | 352 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2024 | 795 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 412 | 0.150 |
Why?
|
| Pennsylvania | 1 | 2018 | 95 | 0.150 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 358 | 0.150 |
Why?
|
| Syndrome | 1 | 2018 | 450 | 0.150 |
Why?
|
| Physician-Patient Relations | 1 | 2023 | 624 | 0.150 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 102 | 0.140 |
Why?
|
| Universities | 1 | 2018 | 146 | 0.140 |
Why?
|
| Intestinal Obstruction | 1 | 2017 | 89 | 0.140 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2016 | 18 | 0.140 |
Why?
|
| Epigenesis, Genetic | 2 | 2012 | 521 | 0.140 |
Why?
|
| DNA Modification Methylases | 1 | 2016 | 28 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 855 | 0.140 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 848 | 0.140 |
Why?
|
| DNA Repair Enzymes | 1 | 2016 | 55 | 0.140 |
Why?
|
| Environmental Monitoring | 2 | 2021 | 80 | 0.130 |
Why?
|
| Chlorpyrifos | 2 | 2007 | 4 | 0.130 |
Why?
|
| Cytokines | 1 | 2020 | 811 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 384 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2019 | 9203 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 330 | 0.130 |
Why?
|
| Carcinogens, Environmental | 1 | 2015 | 7 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 34 | 0.120 |
Why?
|
| Publications | 1 | 2015 | 27 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 289 | 0.120 |
Why?
|
| Colonic Neoplasms | 3 | 2009 | 571 | 0.120 |
Why?
|
| Sunburn | 1 | 2014 | 8 | 0.120 |
Why?
|
| Louisiana | 1 | 2014 | 18 | 0.120 |
Why?
|
| Heat Stress Disorders | 1 | 2014 | 12 | 0.120 |
Why?
|
| Disaster Planning | 1 | 2014 | 24 | 0.120 |
Why?
|
| Exanthema | 1 | 2014 | 40 | 0.110 |
Why?
|
| Time Factors | 2 | 2021 | 5357 | 0.110 |
Why?
|
| Fungi | 1 | 2014 | 66 | 0.110 |
Why?
|
| Adolescent | 2 | 2024 | 9339 | 0.110 |
Why?
|
| Sleep Deprivation | 1 | 2014 | 138 | 0.110 |
Why?
|
| Decision Making | 1 | 2018 | 670 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 2000 | 0.100 |
Why?
|
| Oman | 1 | 2011 | 5 | 0.100 |
Why?
|
| Arabs | 1 | 2011 | 16 | 0.100 |
Why?
|
| Cdh1 Proteins | 1 | 2010 | 1 | 0.090 |
Why?
|
| Biomarkers | 1 | 2017 | 1775 | 0.090 |
Why?
|
| Sulfites | 1 | 2010 | 31 | 0.090 |
Why?
|
| Leukocytes | 1 | 2011 | 209 | 0.090 |
Why?
|
| SEER Program | 2 | 2009 | 205 | 0.090 |
Why?
|
| Cardia | 1 | 2009 | 5 | 0.080 |
Why?
|
| Nicotinic Acids | 1 | 2009 | 8 | 0.080 |
Why?
|
| Child | 1 | 2020 | 7242 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 919 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2010 | 96 | 0.080 |
Why?
|
| Life Style | 2 | 2008 | 176 | 0.080 |
Why?
|
| Greenland | 1 | 2008 | 6 | 0.080 |
Why?
|
| Captan | 1 | 2008 | 1 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1083 | 0.080 |
Why?
|
| Cause of Death | 1 | 2009 | 269 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2007 | 6780 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 399 | 0.080 |
Why?
|
| Nitriles | 1 | 2008 | 156 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 538 | 0.070 |
Why?
|
| Connecticut | 2 | 2004 | 26 | 0.070 |
Why?
|
| Nitrates | 1 | 2007 | 35 | 0.070 |
Why?
|
| Water Supply | 1 | 2007 | 61 | 0.070 |
Why?
|
| Health Status | 1 | 2009 | 371 | 0.070 |
Why?
|
| Dicamba | 1 | 2006 | 1 | 0.070 |
Why?
|
| Brain | 1 | 2017 | 2304 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 1469 | 0.070 |
Why?
|
| Montana | 1 | 2006 | 9 | 0.070 |
Why?
|
| North Dakota | 1 | 2006 | 10 | 0.070 |
Why?
|
| South Dakota | 1 | 2006 | 47 | 0.070 |
Why?
|
| Minnesota | 1 | 2006 | 44 | 0.070 |
Why?
|
| Triazines | 1 | 2006 | 54 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2006 | 59 | 0.060 |
Why?
|
| Carcinoma | 1 | 2009 | 438 | 0.060 |
Why?
|
| Hematologic Neoplasms | 2 | 2006 | 344 | 0.060 |
Why?
|
| Chromatography, Gas | 1 | 2005 | 28 | 0.060 |
Why?
|
| Buttocks | 1 | 2005 | 10 | 0.060 |
Why?
|
| Parity | 1 | 2005 | 97 | 0.060 |
Why?
|
| Menopause | 1 | 2005 | 76 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2004 | 7 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 366 | 0.060 |
Why?
|
| India | 1 | 2005 | 125 | 0.060 |
Why?
|
| Glycine | 1 | 2005 | 95 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3470 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2005 | 234 | 0.060 |
Why?
|
| Competency-Based Education | 1 | 2024 | 38 | 0.060 |
Why?
|
| Mouth Neoplasms | 1 | 2006 | 198 | 0.060 |
Why?
|
| Research Design | 2 | 2004 | 591 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2007 | 333 | 0.060 |
Why?
|
| Breast | 1 | 2005 | 292 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 684 | 0.050 |
Why?
|
| Fatigue | 1 | 2024 | 174 | 0.050 |
Why?
|
| Prognosis | 1 | 2010 | 3796 | 0.050 |
Why?
|
| Certification | 1 | 2023 | 61 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 493 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 66 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 523 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2005 | 871 | 0.050 |
Why?
|
| Turtles | 1 | 2021 | 15 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 55 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 311 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1801 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 825 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 469 | 0.050 |
Why?
|
| Vaccination | 1 | 2023 | 279 | 0.050 |
Why?
|
| Empathy | 1 | 2022 | 151 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 331 | 0.040 |
Why?
|
| Vertebrates | 1 | 2021 | 105 | 0.040 |
Why?
|
| Fishes | 1 | 2021 | 140 | 0.040 |
Why?
|
| Birds | 1 | 2021 | 166 | 0.040 |
Why?
|
| Pregnancy | 1 | 2005 | 3040 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 1544 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 981 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 140 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2010 | 72 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 404 | 0.020 |
Why?
|
| Nervous System Neoplasms | 1 | 2010 | 11 | 0.020 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2010 | 17 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2010 | 54 | 0.020 |
Why?
|
| Patients | 1 | 2010 | 102 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 377 | 0.020 |
Why?
|
| Nitroso Compounds | 1 | 2007 | 12 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 261 | 0.020 |
Why?
|
| Leukemia | 1 | 2010 | 322 | 0.020 |
Why?
|
| Amines | 1 | 2007 | 28 | 0.020 |
Why?
|
| Food Contamination | 1 | 2007 | 32 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 80 | 0.020 |
Why?
|
| Employment | 1 | 2007 | 53 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 171 | 0.020 |
Why?
|
| Poland | 1 | 2007 | 18 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 16 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2007 | 26 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1075 | 0.020 |
Why?
|
| Water | 1 | 2007 | 286 | 0.020 |
Why?
|
| Accidents, Occupational | 1 | 2005 | 8 | 0.020 |
Why?
|
| Spouses | 1 | 2005 | 32 | 0.020 |
Why?
|
| Lymphoma | 1 | 2006 | 266 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 595 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1250 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 344 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 27526 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 264 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 716 | 0.010 |
Why?
|